æÇÃÀGLP-1¶àëĹú¼ÊÃ÷ÐDzúÆ·£¡½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú¶àëÄÐÂÒ©ÔÚ·ÊÅÖÖÎÁÆÁìÓòÈ¡µÃÁÙ´²Ç°ÐÂÍ»ÆÆ-½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú-ÒøÐÓÒ¶£¬ £¬ £¬£¬£¬ÂȵªÆ½"/> ½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú-ÒøÐÓÒ¶£¬ £¬ £¬£¬£¬ÂȵªÆ½ ÒøÐÓÒ¶,Þ½ÏãÕýÆøË®,ŵ·úɳÐÇ,ÂȵªÆ½,ÑÎËáÂȱûàº,С¶ùÖ¹¿ÈÌǽ¬,Í·æß¿ËÂå¿ÅÁ£,ºìÂÝÃ¹ËØ¿ÅÁ£,Å£» £»£»£»£» £»£»ÇËá¿ÅÁ£,Í´¾­Äþ¿ÅÁ£,ÐÂÉú»¯¿ÅÁ£,°¢¹éÑøÑªÌǽ¬,½ðÒø»¨Â¶"/> ½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú-ÒøÐÓÒ¶£¬ £¬ £¬£¬£¬ÂȵªÆ½"/> æÇÃÀGLP-1¶àëĹú¼ÊÃ÷ÐDzúÆ·£¡½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú¶àëÄÐÂÒ©ÔÚ·ÊÅÖÖÎÁÆÁìÓòÈ¡µÃÁÙ´²Ç°ÐÂÍ»ÆÆ-½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú-ÒøÐÓÒ¶£¬ £¬ £¬£¬£¬ÂȵªÆ½"/> ½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú-ÒøÐÓÒ¶£¬ £¬ £¬£¬£¬ÂȵªÆ½ ÒøÐÓÒ¶,Þ½ÏãÕýÆøË®,ŵ·úɳÐÇ,ÂȵªÆ½,ÑÎËáÂȱûàº,С¶ùÖ¹¿ÈÌǽ¬,Í·æß¿ËÂå¿ÅÁ£,ºìÂÝÃ¹ËØ¿ÅÁ£,Å£» £»£»£»£» £»£»ÇËá¿ÅÁ£,Í´¾­Äþ¿ÅÁ£,ÐÂÉú»¯¿ÅÁ£,°¢¹éÑøÑªÌǽ¬,½ðÒø»¨Â¶"/>

½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú

ͼƬÃû³Æ

ÐÂÎÅ×ÊѶ

æÇÃÀGLP-1¶àëĹú¼ÊÃ÷ÐDzúÆ·£¡½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú¶àëÄÐÂÒ©ÔÚ·ÊÅÖÖÎÁÆÁìÓòÈ¡µÃÁÙ´²Ç°ÐÂÍ»ÆÆ

ÈÕÆÚ£º

2026Äê04ÔÂ02ÈÕ 14:40


ÔÚ·ÊÅÖ¼°Ïà¹Ø´úлÐÔ¼²²¡³ÉΪȫÇòÐÔ¿µ½¡Ìôսȷµ±Ï£¬ £¬ £¬£¬£¬½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú£¨ÒÔϼò³Æ“½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú”£©´«À´Õñ·ÜÈËÐĵÄÐÂÎÅ£¡Æä×ÔÖ÷Ñз¢µÄÁ¢ÒìС·Ö×Ó»·ëÄÒ©ÎMCR»·ëÄ£©£¬ £¬ £¬£¬£¬ÔÚÕë¶ÔDB/DB·ÊÅÖСÊóÄ£×ÓµÄÁÙ´²Ç°Ñо¿ÖУ¬ £¬ £¬£¬£¬Õ¹ÏÖ³öÓÅÓÚÏÖÓÐÃ÷ÐÇÒ©ÎïGLP-1¶àëĵļõÖØÐ§¹û£» £»£»£»£» £»£»ÍŽáÆä¶Ô¼¡ÈâµÄ¼á³Ö×÷Ó㬠£¬ £¬£¬£¬ÒÔ¼°¶ÔѪÌÇ¡¢ÑªÖ¬µÈ´úлָ±êµÄ×ۺϵ÷Àí×÷Ó㬠£¬ £¬£¬£¬ÓÐÍû´øÀ´²î±ð»¯µÄÁÙ´²Ñ¡Ôñ ¡£¡£¡£¡£¡£¡£¡£¡£

Ò»¡¢¾ªÑ޵ļõÖØÊý¾Ý

DB/DBСÊóÊÇÑо¿·ÊÅÖºÍ2ÐÍÌÇÄò²¡µÄ¾­µä¶¯ÎïÄ£×Ó£¬ £¬ £¬£¬£¬ÆäÓÉÓÚ»ùÒòÍ»±äµ¼ÖÂÊÝËØÊÜÌ幦ЧȱÏÝ£¬ £¬ £¬£¬£¬ÌåÏÖ³öÑÏÖØµÄ·ÊÅÖ¡¢¸ßѪÌǺʹúлÔÓÂÒµÈÖ¢×´ ¡£¡£¡£¡£¡£¡£¡£¡£ÔÚ½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú¿ªÕ¹µÄÕâÏîÁÙ´²Ç°Ñо¿ÖУ¬ £¬ £¬£¬£¬¹«Ë¾×ÔÑеÄС·Ö×Ó»·ëÄÕ¹ÏÖ³öÓÅÒìµÄ¼õÖØÐ§¹û ¡£¡£¡£¡£¡£¡£¡£¡£

ÊÔÑéЧ¹ûÏÔʾ£¬ £¬ £¬£¬£¬¾­ÓÉΪÆÚ8ÖܵÄÖÎÁÆ£¬ £¬ £¬£¬£¬Óë¿Õȱ±ÈÕÕ×éDB/DBСÊóÏà±È£¬ £¬ £¬£¬£¬MCR»·ëĽϸ߼ÁÁ¿×éµÄСÊóµÄÌåÖØÏ½µ·ù¶ÈԼΪGLP-1¶àëÄ×éµÄ1.25±¶£¬ £¬ £¬£¬£¬Ê¹DB/DBСÊóµÄÌåÖØÔöÌíÇ÷ÊÆÏÔ×Å·Å»º£¬ £¬ £¬£¬£¬¿¿½ü¿µ½¡±ÈÕÕ×éˮƽ ¡£¡£¡£¡£¡£¡£¡£¡£

 

 

¶þ¡¢¶àÏî´úлָ±êÖÜÈ«¸ÄÉÆ

MCR»·ëĽϸ߼ÁÁ¿×éÔÚ¸ÄÉÆ¸ÊÓÍÈýõ¥£¨TG£©¡¢¸ßÃܶÈÖ¬ÂѰ׵¨¹Ì´¼£¨HDL-C£©¡¢ÑªÌÇ¡¢ÄòÌÇˮƽ·½Ã棬 £¬ £¬£¬£¬Í¬ÑùÌåÏÖÓÅÒ죺

1.TGˮƽ£ºÏÔÖø½µµÍDB/DBСÊóµÄTGˮƽ£¬ £¬ £¬£¬£¬ÓÅÓÚGLP-1¶àëÄ×飻 £»£»£»£» £»£»

2.HDL-Cˮƽ£ºÏÔ×ÅÉý¸ß£¬ £¬ £¬£¬£¬ÓÅÓÚGLP-1¶àëÄ×飻 £»£»£»£» £»£»ÓÐÖúÓÚ½µµÍ¶¯ÂöÖàÑùÓ²»¯Î£º¦£» £»£»£»£» £»£»

3.ѪÌÇˮƽ£ºÖÎÁÆ6ÖܵĽµµÍѪÌÇŨ¶ÈˮƽÓëGLP-1¶àëÄ×é¿¿½ü£» £»£»£»£» £»£»

4.ÄòÌÇˮƽ£ºÖÎÁÆ8Öܽ«ÄòÌÇˮƽ´Ó»ùÏß½µÖÁÒ»°ë£» £»£»£»£» £»£»

5.ÌÇ»¯ÑªºìÂѰף¨HbA1c£©£ºÓëÄ£×Ó×éÏà±È£¬ £¬ £¬£¬£¬HbA1cϽµ·ù¶È´ïÔ¼1/3 ¡£¡£¡£¡£¡£¡£¡£¡£

|ÍŽáDZÁ¦

ÖµµÃÒ»ÌáµÄÊÇ£¬ £¬ £¬£¬£¬½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚÒÑ¿ªÕ¹ÁË»·ëÄÓëGLP-1ÀàÒ©ÎÈçGLP-1¶àëÄ£©ÍŽáʹÓõÄÑо¿£¬ £¬ £¬£¬£¬Ð§¹ûÏÔʾÔÚÒûʳÓÕµ¼µÄ·ÊÅÖСÊóÄ£×ÓÖУ¬ £¬ £¬£¬£¬Á½ÕßÔÚ¼õÖØÐ§¹û¼°¼¡Èâ±£» £»£»£»£» £»£»¤·½Ãæ¾ßÓÐÃ÷È·µÄЭͬЧӦ£º

1.Эͬ¼õÖØ£ºÁªÊÊÓÃÒ©×éÌåÏÖ³ö¸üÏÔÖøµÄ¼õÖØÐ§¹û£¬ £¬ £¬£¬£¬ÓÅÓÚµ¥Ò©ÖÎÁÆ£» £»£»£»£» £»£»

2.ïÔÌ­¼¡ÈâÁ÷ʧ£º»·ëÄÔÚÁªÓÃÖÐÓÐÓûº½âGLP-1ÀàÒ©Îï´øÀ´µÄ¼¡ÈâÁ÷ʧÎÊÌ⣬ £¬ £¬£¬£¬Ìá¸ßÕûÌåÖÎÁÆÇå¾²ÐÔ ¡£¡£¡£¡£¡£¡£¡£¡£

Èý¡¢¶à°ÐµãЭͬ×÷Ó㺻·ëĵÄÁ¢Òì»úÖÆ

MCR»·ëÄÖ®ÒÔÊÇÄܹ»ÔÚ¼õÖØ¼°ÆäËû´úлָ±êÉÏÈ¡µÃÔÆÔÆÓÅÒìµÄЧ¹û£¬ £¬ £¬£¬£¬ÓëÆäÆæÒìµÄ×÷ÓûúÖÆÃܲ»¿É·Ö ¡£¡£¡£¡£¡£¡£¡£¡£×÷ΪһÖÖС·Ö×Ó»·ëÄÒ©Î £¬ £¬£¬£¬Äܹ»Í¬Ê±¾«×¼×÷ÓÃÓÚMC4RºÍMC1RÁ½¸öÒªº¦°Ðµã£¬ £¬ £¬£¬£¬Í¨¹ý¶à°ÐµãЭͬ×÷Ó㬠£¬ £¬£¬£¬Ê©Õ¹Æä׿ԽµÄ´úлµ÷Àí¹¦Ð§ ¡£¡£¡£¡£¡£¡£¡£¡£

|¼¤»îMC4R£ºÒÖÖÆÊ³Óû£¬ £¬ £¬£¬£¬Ôö½øÖ¬·¾ÆÊÎö

MC4RÊÇÖÐÊàÉñ¾­ÏµÍ³µ÷¿ØÄÜÁ¿Æ½ºâµÄÒªº¦ÊÜÌå ¡£¡£¡£¡£¡£¡£¡£¡£½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚMCR»·ëÄ×÷ΪMC4R¼¤¶¯¼Á£¬ £¬ £¬£¬£¬Äܹ»Ôö½øÖ¬·¾ÆÊÎö£¬ £¬ £¬£¬£¬ÒÖÖÆÖ¬·¾ÌìÉú£» £»£»£»£» £»£»Ôö½ø°×ɫ֬·¾×éÖ¯ºÖ±ä£» £»£»£»£» £»£»Ìá¸ßÒȵºËØÃô¸ÐÐÔ£» £»£»£»£» £»£»ÔÚ²»ÏÔÖøÒÖÖÆÊ³ÓûµÄÌõ¼þÏÂʵÏÖ¼õÖ¬£¬ £¬ £¬£¬£¬×èÖ¹Ñáʳ¸±×÷ÓÃ1 ¡£¡£¡£¡£¡£¡£¡£¡£

 

 

|¼¤»îMC1R:¿¹Ñ×ÃâÒßµ÷Àí£¬ £¬ £¬£¬£¬»Ö¸´ÊÝËØÃô¸ÐÐÔ

MC1RÖ÷Òª¼ÓÈëÃâÒßµ÷ÀíºÍÑ×Ö¢·´Ó¦ ¡£¡£¡£¡£¡£¡£¡£¡£Í¨¹ý¼¤»îMC1R£¬ £¬ £¬£¬£¬Äܹ»ÏÔÖø¸ÄÉÆÌåÄÚÑ×֢΢ÇéÐΣ¬ £¬ £¬£¬£¬½µµÍÑ×Ö¢Òò×Ó£¨°üÀ¨IL-1, TNF-a, IL-6, IL-8, and IL-12, iNOSµÈ£©µÄ±í´ï´Ó¶ø»Ö¸´ÊÝËØÃô¸ÐÐԺ͵÷ÀíÃâÒß·´Ó¦£¬ £¬ £¬£¬£¬¶Ô×ÔÉíÃâÒßÐÔ¼²²¡¾ßÓÐDZÔÚÖÎÁƼÛÖµ2 ¡£¡£¡£¡£¡£¡£¡£¡£

ËÄ¡¢ÁÉÀ«µÄÓ¦ÓÃÔ¶¾°£º´úлÔÓÂÒÓë×ÔÉíÃâÒß˳Ӧ֢

»ùÓÚMCR»·ëÄÔÚÁÙ´²Ç°Ñо¿ÖÐÕ¹ÏÖ³öµÄ׿Խ¼õÖØÐ§¹ûºÍ¶àϵͳ´úл¸ÄÉÆ×÷Ó㬠£¬ £¬£¬£¬½ñÄê»á¹ÙÍøµÇ¼Èë¿Ú¶ÔÆäδÀ´ÔÚ´úлºÍ×ÔÃâÁìÓòÖеÄÓ¦ÓÃÔ¶¾°³äÂúÐÅÐÄ ¡£¡£¡£¡£¡£¡£¡£¡£

´úл×ÛºÏÕ÷¼°Æä²¢·¢Ö¢·½Ã棬 £¬ £¬£¬£¬MCR»·ëIJ»µ«ÄܼõÖØ£¬ £¬ £¬£¬£¬»¹ÄÜͬ²½¸ÄÉÆÑªÌÇ¡¢ÑªÖ¬¡¢HbA1c¡¢ÄòÌǵȶàÏîÖ¸±ê£¬ £¬ £¬£¬£¬¶Ô2ÐÍÌÇÄò²¡¡¢·Ç¾Æ¾«ÐÔÖ¬·¾ÐԸβ¡¡¢¸ßѪѹ¡¢¶¯ÂöÖàÑùÓ²»¯µÈ´úл×ÛºÏÕ÷×é·ÖÖ®Ò»»ò¶àÏî¾ßÓиÉԤDZÁ¦ ¡£¡£¡£¡£¡£¡£¡£¡£

×ÔÉíÃâÒßÓëÑ×Ö¢Ïà¹Ø¼²²¡·½Ã棬 £¬ £¬£¬£¬ÓÉÓÚÆä¾ß±¸ÏÔÖøµÄ¿¹Ñ׺ÍÃâÒßµ÷Àí×÷Ó㬠£¬ £¬£¬£¬Î´À´ÓÐÍûÍØÕ¹ÖÁÀà·çʪÐÔÊàŦÑ×£» £»£»£»£» £»£»ÂýÐÔÉö² ¡£¡£¡£¡£¡£¡£¡£¡£¨CKD£©£» £»£»£»£» £»£»ÌÇÄò²¡Éö² ¡£¡£¡£¡£¡£¡£¡£¡£¨DN£©µÈ˳Ӧ֢ ¡£¡£¡£¡£¡£¡£¡£¡£

½ÓÏÂÀ´£¬ £¬ £¬£¬£¬¹«Ë¾½«¼ÌÐøÍÆ¶¯¶àëÄÐÂÒ©µÄÁÙ´²Ç°Ò©ÀíѧºÍ¶¾ÀíѧÑо¿£¬ £¬ £¬£¬£¬ÕùÈ¡ÔçÈÕ½«ÐÂÒ©ÍÆÏòÁÙ´²½×¶Î£¬ £¬ £¬£¬£¬ÔÚÒÑÊÚȨµÄרÀû¼Ó³ÖÏ£¬ £¬ £¬£¬£¬¿ìËÙ½«²î±ð»¯µÄºÃÒ©´ø¸øÓµÓÐÏà¹ØÖÎÁÆÐèÇóµÄ»¼ÕßȺÌå ¡£¡£¡£¡£¡£¡£¡£¡£

ÎÄÕÂȪԴÓÚҩʱ´ú¹«ÖÚºÅ

²Î¿¼ÎÄÏ×

1. Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022). Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal transduction and targeted therapy, 7(1), 298.https://doi.org/10.1038/s41392-022-01149-x

2. Mun, Y., Kim, W., & Shin, D. (2023). Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects. International journal of molecular sciences, 24(15),12152. https://doi.org/10.3390/ijms241512152

Ïà¹ØÍÆ¼ö

ÍøÕ¾µØÍ¼